Improving the residual risk of renal and cardiovascular outcomes in diabetic kidney disease: A review of pathophysiology, mechanisms, and evidence from recent trials-Reference-Cited by-同舟云学术

Improving the residual risk of renal and cardiovascular outcomes in diabetic kidney disease: A review of pathophysiology, mechanisms, and evidence from recent trials

Published:2021-12 Issue: Volume: Page:
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Chaudhuri Ajay¹²,Ghanim Husam¹^ORCID,Arora Pradeep³

Affiliation:

1. Division of Endocrinology and Metabolism Jacobs School of Medicine and Biomedical Sciences, University at Buffalo Buffalo New York USA

2. Diabetes Center Kaleida Health Buffalo New York USA

3. Buffalo VA Medical Center Jacobs School of Medicine and Biomedical Sciences, University at Buffalo Buffalo New York USA

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14601

Reference87 articles.

1. US Centers for Disease Control and Prevention. National diabetes statistics report 2020.https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf. Accessed February 24 2020.

2. US Centers for Disease Control and Prevention. Chronic kidney disease in the United States 2019.https://www.cdc.gov/kidneydisease/pdf/2019_National-Chronic-Kidney-Disease-Fact-Sheet.pdf. Accessed April 16 2021.

3. Kidney Disease and Increased Mortality Risk in Type 2 Diabetes

4. Treating Elderly People with Diabetes and Stages 3 and 4 Chronic Kidney Disease

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association Between Kidney Disease Index and Decline in Cognitive Function with Mediation by Arterial Stiffness in Asians with Type 2 Diabetes;Journal of Alzheimer's Disease Reports;2024-09-05

2. Systemic inflammation and health outcomes in patients receiving treatment for atherosclerotic cardiovascular disease;European Heart Journal;2024-08-30

3. Finerenone and diabetic renal disease: a narrative review;Endocrine;2024-08-14

4. Kidney and cardiovascular-protective benefits of combination drug therapies in chronic kidney disease associated with type 2 diabetes;BMC Nephrology;2024-08-01

5. A new perspective on proteinuria and drug therapy for diabetic kidney disease;Frontiers in Pharmacology;2024-07-31